SecBot SecBot
SECBOTREPLAY Home › Report › EBS

EBS · Emergent BioSolutions Inc

Emergent BioSolutions Inc. · DEFA14A filed Apr 16, 2026 at 09:30 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 16, 2026 at 09:30 ET

Emergent BioSolutions Inc. filed its definitive proxy statement for the 2026 annual shareholder meeting, scheduled for April 29, 2026. The filing serves as a reminder for shareholders to vote on matters including director elections and executive compensation, with voting accessible via proxy.

  • Filing is a Definitive Proxy Statement (DEFA14A) for the 2026 annual meeting.
  • Annual meeting date is April 29, 2026, at 9:00 AM Eastern Time.
  • Shareholders of record as of March 6, 2026, are eligible to vote.
  • Voting can be completed by proxy, with instructions sent via email through E*TRADE.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access